IL10 and acute kidney injury: As expected, neutralizing IL-10 antibody supplementation abrogated the DN T cells-mediated improvement in cisplatin-induced HK-2 cells, highlighting that IL-10 is a critical mediator of the role of DN T cells in attenuating cisplatin-induced AKI.